Latest News about REGN
Recent news which mentions REGN
From Motley Fool
2 Ultra-Risky Coronavirus Stocks That Could Make You Filthy Rich
December 01, 2020
From Motley Fool
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
November 28, 2020
From Motley Fool
Is This Coronavirus Treatment Setting Investors Up for Failure?
November 27, 2020
From Motley Fool
A Small Company Worth Watching
November 26, 2020
From Motley Fool
Reinventing Vaccines To Save Lives And The Economy
November 24, 2020
From Benzinga
Can Coronavirus Vaccine Stocks Keep Lifting the Stock Market?
November 23, 2020
From Motley Fool
U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections
November 23, 2020
From MarketWatch
Looking Into Regeneron Pharmaceuticals's Return On Capital Employed
November 23, 2020
Tickers
REGN
From Benzinga
BlackRock upgrades U.S. stocks but calls for investors to adopt this ‘nuanced’ approach
November 23, 2020
From MarketWatch
40 Stocks Moving in Monday's Pre-Market Session
November 23, 2020
From Benzinga
A Peek Into The Markets: US Stock Futures Gain On Covid-19 Vaccine News
November 23, 2020
From Benzinga
6 Stocks To Watch For November 23, 2020
November 23, 2020
From Benzinga
Positive Vaccine News, Economic Recovery Lift Global Markets
November 23, 2020
From Benzinga
Sorrento Therapeutics' Slow-But-Steady Approach to COVID-19
November 22, 2020
From Motley Fool
Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA
November 22, 2020
From Motley Fool
Regeneron's COVID Treatment Gets Emergency FDA Approval
November 22, 2020
Tickers
REGN
From Benzinga
3 Best Pharma Stocks to Buy Right Now
November 22, 2020
From Motley Fool
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
November 22, 2020
From Motley Fool
Sorrento Therapeutics' Next-Generation COVID-19 Therapeutic Antibody
November 21, 2020
From Motley Fool
Is There Room for Latecomers to the COVID-19 Party?
November 21, 2020
From Motley Fool
Sorrento Therapeutics on COVID-19 Therapy Competition: "Our Antibody Is Better Than Theirs"
November 20, 2020
From Motley Fool
From Benzinga
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
November 17, 2020
From Motley Fool
From Benzinga
Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%
November 09, 2020
From MarketWatch
Aspirin to be investigated as potential treatment for COVID-19
November 06, 2020
Tickers
REGN
Tags
REGN
From MarketWatch
Dow futures up nearly 400 points as stocks continue election week rally
November 05, 2020
From MarketWatch
These 7 unloved stocks are for the long haul, says contrarian manager
November 05, 2020
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.